JW PHARMACEUTICAL Logo

JW PHARMACEUTICAL

Develops and commercializes pharmaceuticals, OTC solutions, and nutritional infusions.

001060 | KO

Overview

Corporate Details

ISIN(s):
KR7001060003
LEI:
Country:
South Korea
Address:
경기도 과천시 과천대로7길 38 -, 과천시

Description

JW Pharmaceutical is a company focused on the research, development, and commercialization of pharmaceutical products. It provides a broad portfolio of therapeutic drugs, including specialty medicines and over-the-counter (OTC) solutions. Key product areas include nutritional infusions (Combiflex®, Winuf®), treatments for neutropenia (Neutrogin®), and cardiovascular medicines (Livalo®). Its consumer healthcare offerings feature the Hi-mom® brand of advanced wound care products. The company emphasizes innovation, advancing a pipeline of new drugs targeting oncology and immune diseases. This research is driven by proprietary technology platforms and includes candidates such as the gout treatment Epaminurad.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-16 00:00
주주명부폐쇄기간또는기준일설정
Korean 4.1 KB
2025-12-16 00:00
기타경영사항(자율공시) (배당기준일 변경 안내)
Korean 6.0 KB
2025-08-14 00:00
반기보고서 (2025.06)
Korean 3.1 MB
2025-07-31 00:00
영업(잠정)실적(공정공시)
Korean 13.3 KB
2025-07-31 00:00
공정거래자율준수프로그램운영현황(안내공시)
Korean 30.7 KB
2025-07-02 00:00
주식등의대량보유상황보고서(약식)
Korean 62.4 KB
2025-07-01 00:00
주식등의대량보유상황보고서(일반)
Korean 103.8 KB
2025-06-25 00:00
자기주식취득결과보고서
Korean 62.4 KB
2025-06-13 00:00
벌금등의부과
Korean 5.9 KB
2025-05-30 00:00
기업지배구조보고서공시
Korean 928.8 KB
2025-05-15 00:00
분기보고서 (2025.03)
Korean 2.4 MB
2025-05-07 00:00
영업(잠정)실적(공정공시)
Korean 13.3 KB
2025-04-21 00:00
기업가치제고계획(자율공시) (2025년)
Korean 7.5 KB
2025-04-04 00:00
최대주주등소유주식변동신고서
Korean 40.6 KB
2025-04-04 00:00
주식등의대량보유상황보고서(일반)
Korean 109.2 KB

Automate Your Workflow. Get a real-time feed of all JW PHARMACEUTICAL filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for JW PHARMACEUTICAL

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for JW PHARMACEUTICAL via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.